Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NanoScent to sign MOU for $20M in Series A round led by Dreamtech
  • USA - English

NanoScent to sign MOU for $20M in Series A round led by the Dreamtech. NanoScent and Dreamtech to expand their strategic partnership to further develop and introduce the revolutionary Scent Reader technology to early stage Covid-19 detection.


News provided by

NanoScent LTD

Dec 09, 2020, 07:00 ET

Share this article

Share toX

Share this article

Share toX

MISGAV, Israel, Dec. 9, 2020 /PRNewswire-PRWeb/ -- Earlier this year the Israeli startup was granted 2.5M euros by the EIC accelerator (European Innovation Council) to develop its breakthrough technology for ultra-fast Covid-19 screening based on a unique "scent" signature produced by a persons' response to the virus. Along with the grant the European Investment Bank suggested a future investment of 8 Million euros into the bright minds from the Galilee.

By signing this MOU, Dreamtech is initiating a $20M funding round. Dreamtech and NanoScent strengthen their strategic partnership for healthcare innovative solutions. NanoScent is using this financial round to move faster into the development and validation stages of its unique technology for Covid-19 screening. Dreamtech and NanoScent started their collaboration in 2019 using the KORIL framework (Korea-Israeli industrial R&D foundation), by signing this agreement the companies express mutual trust and high level of appreciation for each other's capabilities. Through this MOU both companies committed actively working on the deployment in Korea as well as the regulatory approval by the 1st half of next year. Dreamtech has designated the healthcare sector as its new growth engine and NanoScent as its strategic partner.

NanoScent successfully completed usability trials in the Premier League during early October this year. Tottenham Spurs are leading the efforts of bringing back the fans into the stadiums and NanoScent is pioneering their technology to fulfill this wish. The non-invasive test is considered 10X times better experience than the standard PCR. It also provided a match to PCR tested (all negative in group). Furthermore, NanoScent is working with an NBA club in the US regarding integration of NS solution into the flow of bringing the fans and the employees back to the stadium. Now the challenge remains to stabilize the service for mass usage. NanoScent is aligned with many scholars saying constant testing should be the right approach to mitigate the risk. As reported by the CNN, https://edition.cnn.com/2020/11/20/health/cdc-coronavirus-spread-asymptomatic-website-wellness/index.html, the virus is spread by many asymptomatic carriers, thus the Scent Recognition test developed by NanoScent could possibly identify those and truly be a game changer to the current and future pandemics. The fact that the technology is coupled with Machine Learning capabilities will allow it to be highly adaptable for future mutations of the virus.

Hyoung Min Kim, CEO of Dreamtech – "both companies are committed to the successful commercialization of 'scent reader' solutions worldwide. And through this MOU, both companies will further strengthen the strategic partnership become a leading company in the healthcare market"

Oren Gavriely, CEO & Co-Founder of NanoScent - "both companies are committed to make breakthrough technologies a reality. For the past three years we have been walking step by step alongside to create this strong bond that can now become a global solution for defining the post-covid normal".

Dreamtech Co., LTd. was founded in 1998, Dreamtech engage in the design and manufacturing of modular solutions for mobile and healthcare appliances. Working closely with customers from the product development phase, Dreamtech develops customized modules that satisfy the customers' functional needs while meeting necessary cost requirements. Dreamtech operates 8 factories, which located in the most cost effective countries such as China and Vietnam. Its major products include integrated printed board assembly ("PBA"), various sensor modules including fingerprint sensors, and other modules for mobile phones, wireless biosensor for monitoring ECG, and intraoperative orthopedic sensors for total knee arthroplasty.

NanoScent Ltd was co-founded in 2017 by Oren Gavriely and Eran Rom, aimed at developing a scent recognition technology, capable of improving the safety and personal well-being of individuals, in addition to providing environmental protection and energy efficiency. NanoScent's customers include Sumitomo Chemical, Continental and Kimberly-Clark, who are using the technology for leak detection, nutrition and wellness applications. The NanoScent reader is a new application of the technology which specifically detects VOC signatures in the expelled nasal air of people infected with SARS-CoV-2.

Media Contact

Oded Fishelzon, NanoScent LTD, +1 917 5085164, [email protected]

SOURCE NanoScent LTD

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.